ArticleJACC. Case reports2025
Triple Valve Infective Endocarditis in an Immunocompetent Patient.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTriple valve endocarditis remains extremely rare and is medically challenging due to lack of clinical evidence for best strategy. CASE SUMMARY: A 70-year-old man diagnosed with type 2 diabetes, hypertension, dyslipidemia, and emphysema presented with worsening dyspnea, fatigue, and unintentional weight loss for 5 months. He was diagnosed with triple valve infective endocarditis complicated with decompensated heart failure and severe thrombocytopenia. After medical treatment at initial stage, he underwent successful surgical treatment strategy. DISCUSSION: Enterococcal endocarditis constitutes only 14% of cases in multivalvular infective endocarditis and is associated with relapse and death. This case is unique because the patient was immunocompetent with enterococcal multivalvular infective endocarditis. The index patient did not fulfill criteria for antibiotic prophylaxis and ended up having life-threatening complications, challenging the European Society of Cardiology/American Heart Association guideline-recommended practice. TAKE-HOME MESSAGES: A multidisciplinary approach reduces mortality, and medical optimization before surgery is crucial. This case highlights the need for a tailored approach in cases that do not meet the standard antibiotic prophylaxis criteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.